<?xml version="1.0" encoding="UTF-8"?>
<results title="zoonosis">
 <result pre="Virus protein ligands (e.g., haemagglutinin or trimeric spike glycoprotein for" exact="Influenza" post="and CoV, respectively) interact with cellular receptors, such as"/>
 <result pre="alveolar type II epithelial (ATII) cells are also permissive to" exact="SARS-CoV infection" post="(35, 36). SARS-CoV-2 has also been shown to infect"/>
 <result pre="that domestic animals, including ferrets and cats, are permissive to" exact="SARS-CoV-2 infection." post="In contrast, the virus replicates poorly in pigs, ducks,"/>
 <result pre="protected from pulmonary disease and death following H1N1 and H7N9" exact="Influenza" post="infection, but not from that of the influenza H3N2"/>
 <result pre="above, distal peripheral lung alveolar epithelial cells seem to harbor" exact="SARS-CoV infection" post="in vivo, and although respiratory epithelial cells are known"/>
 <result pre="interface (ALI)] is the model of choice: in that set-up," exact="SARS-CoV infection" post="triggered an inflammatory response characterized by increased production of"/>
 <result pre="interesting tool to study SARS-CoV2-cells interactions (58), as demonstrated in" exact="Influenza" post="infections with human (59) or animal-derived material (60). As"/>
 <result pre="vitro in epithelial cells and in a murine model that" exact="Influenza" post="H3N2 is able to upregulate mucin expression and that"/>
 <result pre="addition to demonstrating the role of TLR pathways in the" exact="SARS-CoV infection," post="suggested a human genetic predisposition to SARS-CoV, and this"/>
 <result pre="have shown increased protease-mediated lung damage in mice infected with" exact="Influenza" post="(81â€&quot;83). Additionally, in a MERS-CoV murine model, it was"/>
 <result pre="from SOCS (suppressors of cytokine signaling) inhibition (85). Indeed, upon" exact="Influenza" post="infection, SOCS1 and SOCS3 were shown to reduce type"/>
 <result pre="epithelial cells (86). Also, SOCS4-deficient mice exhibited heightened sensitivity to" exact="Influenza" post="infection (87). Studies about SOCS involvement during coronavirus infections"/>
 <result pre="received grants from the FacultÃ© de MÃ©decine Sorbonne UniversitÃ© (AAP" exact="COVID19" post="and UniversitÃ© de Paris (Fonds d'urgence SARS-CoV-2 et COVID-19),"/>
 <result pre="human airway epithelium. Pathog Dis. (2013) 69:87â€&quot;100. 10.1111/2049-632X.1205323821437 20.GartenWBradenCArendtAPeitschCBaronJLuYet al.." exact="Influenza" post="virus activating host proteases: identification, localization and inhibitors as"/>
 <result pre="cytokine storm and immunopathology. Semin Immunopathol. (2017) 39:529â€&quot;39. 10.1007/s00281-017-0629-x28466096 33.SimsACBaricRSYountBBurkettSECollinsPLPicklesRJ." exact="Severe acute respiratory syndrome" post="coronavirus infection of human ciliated airway epithelia: role of"/>
 <result pre="coronavirus infection. J Virol. (2019) 93:e01815-18. 10.1128/JVI.01815-1830626688 49.LiKWohlford-LenaneCLChannappanavarRParkJEEarnestJTBairTBet al.. Mouse-adapted" exact="MERS coronavirus" post="causes lethal lung disease in human DPP4 knockin mice."/>
 <result pre="via a toll-like-receptor-related TRAF3-independent mechanism. MBio. (2016) 7:e01872â€&quot;15. 10.1128/mBio.01872-1526861016 56.YoshikawaTHillTLiKPetersCJTsengCT." exact="Severe acute respiratory syndrome" post="(SARS) coronavirus-induced lung epithelial cytokines exacerbate SARS pathogenesis by"/>
 <result pre="J Respir Cell Mol Biol. (2004) 30:470â€&quot;8. 10.1165/rcmb.2003-0199OC14500256 62.BarbierDGarcia-VerdugoIPothlichetJKhazenRDescampsDRousseauKet al.." exact="Influenza" post="A induces the major secreted airway mucin MUC5AC in"/>
 <result pre="and mortality. Cell Host Microbe. (2016) 20:458â€&quot;70. 10.1016/j.chom.2016.09.00527736644 83.VilleretBSolhonneBStraubeMLemaireFCazesAGarcia-VerdugoIet al.." exact="Influenza" post="a virus pre-infection exacerbates Pseudomonas aeruginosa-mediated lung damage through"/>
 <result pre="protects against severe cytokine storm and enhances viral clearance during" exact="influenza infection." post="PLoS Pathog. (2014) 10:e1004134. 10.1371/journal.ppat.100413424809749 88.CalyLDruceJDCattonMGJansDAWagstaffKMThe FDA-approved Drug Ivermectin"/>
</results>
